Edesa Biotech, Inc.

NASDAQ:EDSA

1.59 (USD) • At close January 14, 2025
Bedrijfsnaam Edesa Biotech, Inc.
Symbool EDSA
Munteenheid USD
Prijs 1.59
Beurswaarde 5,513,233
Dividendpercentage 0%
52-weken bereik 1.55 - 5.99
Industrie Biotechnology
Sector Healthcare
CEO Dr. Pardeep Nijhawan FRCPC, M.D.
Website https://www.edesabiotech.com

An error occurred while fetching data.

Over Edesa Biotech, Inc.

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19

Vergelijkbare Aandelen

Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc.

MRKR

2.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)